RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION

RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION

The present report reviews various aspects of legal regulation, function, guidelines for creation and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug supply policy in theRussian Federation. The following restrictive lists (currently in effec...

Full description

Bibliographic Details
Main Author:	M. V. Sura
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2017-05-01
Series:	Фармакоэкономика
Subjects:	restrictive lists of drugs legal regulation of drug supply financing of drug supply state guarantees for free public medical care
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/182

Similar Items

Development of recommendations on creating local formulary drug list for children affected with gastritis and duodenitis
by: V. V. Trokhymchuk, et al.
Published: (2018-08-01)

ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS
by: M. V. Sura, et al.
Published: (2015-05-01)

Public financing of human insulins in Brazil: 2009-2017
by: Leticia Lucia dos Santos Dias, et al.
Published: (2020-07-01)

Drug tendering: drug supply and shortage implications for the uptake of biosimilars
by: Dranitsaris G, et al.
Published: (2017-09-01)

DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY
by: M. V. Avxentyeva, et al.
Published: (2016-12-01)

The revision of the restrictive lists of medicinal products
by: B. K. Romanov, et al.
Published: (2018-02-01)

Blockchain and Supply-Chain Financing: An Evolutionary Game Approach with Guarantee Considerations
by: Jizhou Zhan, et al.
Published: (2024-06-01)

Current Status and Challenges of Guarantee for Rare Disease Drugs
by: ZUO Wei, et al.
Published: (2024-04-01)

Withdrawing Drugs in the U.S. Versus Other Countries
by: Benson Ninan, Pharm.D., et al.
Published: (2012-01-01)

Withdrawing Drugs in the U.S. Versus Other Countries
by: Benson Ninan, et al.
Published: (2012-01-01)

Issues of National Drug Security in Formation of a Reserve of Antibacterial Agents Intended to Eliminate Medical and Sanitary Consequences of Emergencies
by: L. Yu. Chernikova, et al.
Published: (2022-09-01)

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges
by: Theogene Uwizeyimana, et al.
Published: (2021-12-01)

An Open Access Database of Licensed Cancer Drugs
by: Pan Pantziarka, et al.
Published: (2021-03-01)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
by: Hong Zhu, et al.
Published: (2022-07-01)

A Review of Drugs Supply Disruption Risks and Effects that Lead to Shortage
by: Aruna Burinskas
Published: (2020-03-01)

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
by: David Otiashvili, et al.
Published: (2022-03-01)

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024
by: Stefan Kohler, et al.
Published: (2024-06-01)

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871
by: V. V. Omelyanovskiy, et al.
Published: (2020-08-01)

Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting
by: Iva Vlak, et al.
Published: (2023-04-01)

Experiences of the changing illicit drug supply among racial and ethnic minoritized people in three US states: a qualitative study
by: Brendan Saloner, et al.
Published: (2024-11-01)

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
by: A. S. Kolbin, et al.
Published: (2016-04-01)

Drug Audit of Intravenous Anaesthetic Agents in Tertiary Care Hospital
by: Sonali Ramakant More, et al.
Published: (2015-11-01)

The impact of the COVID-19 pandemic on drug demand and supply in Estonia
by: Katri Abel-Ollo, et al.
Published: (2022-05-01)

Curation of an international drug proprietary names dataset
by: Mohammad A. Khaleel, et al.
Published: (2022-02-01)

Supply Chain Finance techniques and risks
by: Francesca Querci
Published: (2023-04-01)

Associations between opioid overdose deaths and drugs confiscated by law enforcement and submitted to crime laboratories for analysis, United States, 2014–2019: an observational studyResearch in context
by: Jon E. Zibbell, et al.
Published: (2023-09-01)

Use of dynamic regression model for reduction of shortages in drug supply
by: Aurelija Burinskienė
Published: (2019-12-01)

COVID-19 and the drug situation in Lithuania
by: Evelina Pridotkienė, et al.
Published: (2022-05-01)

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
by: Marzieh Zargaran, et al.
Published: (2016-01-01)

Cardiovascular Drug Labeling: Do They Have Information on Necessary Precautions for Older People?
by: Lucas Oliveira Marques, et al.
Published: (2024-10-01)

The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States
by: Sarah Mars, et al.
Published: (2024-03-01)

ETATIZAM NA PRIMJERU OBEZBIJEĐENOG SNABDIJEVANJA STANOVNIŠTVA U USLOVIMA POSLIJERATNE OBNOVE I PRVOG PETOGODIŠNJEG PLANA // ETATISM ON THE EXAMPLE OF SECURED SUPPLY OF POPULATION IN CONDITIONS OF POST-WAR RECONSTRUCTION AND THE FIRST FIVE-YEAR PLAN
by: Senaid Hadžić
Published: (2018-10-01)

Factors Influencing Drug Shortages and Their Resolution in South Korean Community Pharmacies
by: Lee YH, et al.
Published: (2024-08-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

Study on Drug List and Accessibility of Rare Diseases Based on the China′s Second List of Rare Diseases
by: LIU Qingyang, et al.
Published: (2024-04-01)

Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists
by: Anna Volerman, et al.
Published: (2022-04-01)

THE PROBLEMS OF BENEFICIAL DRUG SUPPORT
by: L. V. Shukil, et al.
Published: (2015-09-01)

Impact of supply chain finance on the performance of agricultural small and medium-sized enterprises: Evidence from Chinese listed companies
by: Wenji Li, et al.
Published: (2023-11-01)

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein
by: Eva González-Haba-Peña, et al.
Published: (2018-11-01)

Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration
by: William H. Eger, et al.
Published: (2024-08-01)